Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR88 is an orphan G protein-coupled receptor (GPCR) highly expressed in the striatum. It couples to Gi/o proteins, inhibiting adenylyl cyclase activity. GPR88 modulates other GPCRs, such as opioid receptors, and is implicated in neuropsychiatric disorders like ADHD, schizophrenia and bipolar disorder. While the endogenous ligand remains unknown, synthetic agonists have been developed. It is a promising drug target for neuropsychiatric disorders due to its role in modulating striatal function and impulsivity-related behaviors.
Allosteric modulation via binding to a cytoplasmic pocket formed by transmembrane segments 5/6 and part of the α5 helix of Gi1 protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 88 (GPR88).